Published in AIDS Weekly, August 19th, 1996
Dr. Stephen D. Shafran, University of Alberta at Edmonton, Canada, and colleagues reported in the August 8, 1996, issue of the New England Journal of Medicine that the three-drug combination regimen of clarithromycin, rifabutin and ethambutol "... leads to resolution of the bacteremia more frequently and more rapidly than treatment with rifampin, ethambutol, clofazimine, and ciprofloxacin," Survival rates were better in patients who received the three-drug regimen in Shafran's study (N Engl...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.